IBM Stock Rises after Getting Government Approval for Its AI and Automation Tools

FomoAnxiety · 2026-04-01T21:02:52+00:00

IBM announced that 11 of its AI and automation tools are now FedRAMP-approved for U.S. government use, enabling secure adoption without system management. This partnership with AWS enhances modernization in compliance with strict security standards.

FomoAnxiety

2026-04-01 21:02:52

Abstract generation in progress

Earlier today, tech giant IBM IBM +0.31% ▲ announced that 11 of its AI and automation tools, including several from its watsonx lineup, are now approved for use by U.S. government agencies. This approval, known as FedRAMP, means that the software meets strict security and compliance standards. The approval was made possible through a partnership with Amazon Web Services AMZN +1.10% ▲ , as all of these tools run on AWS GovCloud, a secure cloud built specifically for government use.

End of Quarter Sale - 50% Off TipRanks

Trade IBM with leverage

As a result, agencies can use these AI tools without having to manage the systems themselves, thereby making it easier to adopt new technology while staying secure. Unsurprisingly, this is a big step forward for IBM in the government market. In fact, the company said that its number of FedRAMP-approved products has increased fourfold in just one year, which suggests it is making a strong push into this space. IBM explained that government agencies need AI tools that are both powerful and safe to use, especially for sensitive work.

Meanwhile, AWS said that the partnership helps agencies modernize faster while still meeting strict security and reliability requirements, which are critical for government operations. Interestingly, these 11 tools cover a wide range of uses. For instance, some help build and run AI models (like watsonx.ai), while others focus on managing data, making sure AI is used responsibly, and automating tasks to improve efficiency. In addition, there are tools for security, like managing who can access systems, as well as tools that monitor performance and help maintain important infrastructure.

Is IBM a Buy, Sell, or Hold?

Turning to Wall Street, analysts have a Moderate Buy consensus rating on IBM stock based on 11 Buys, six Holds, and zero Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average IBM price target of $332.94 per share implies 37% upside potential.

Disclaimer & DisclosureReport an Issue

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.